Individual differences in the feeding response to CCK(B) antagonists: Role of the nucleus accumbens

Peptides

Volumn 17, Issue 4, 1996, Pages 593-599

  Sills, Terrence L ^a   Vaccarino, Franco J ^b,c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

CCK(A); CCK(B); Cholcystokinin; Devazepide; Feeding; Individual differences; L 365,260; Nucleus accumbens; Rat; Receptors

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; DEVAZEPIDE; PD 135158; SUGAR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FOOD INTAKE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0029951794     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0196-9781(96)00032-0     Document Type: Article

References (49)

1. 1. Cooper, S. J.; Dourish, C. T.; Barber, D. J. Reversal of the anorectic effect of ( + )-fenfluramine in the rat by the selective cholecystokinin receptor antagonist MK-329. Br. J. Pharmacol. 99:75-90; 1990.
2. 2. Corwin, R. L.; Gibbs, J.; Smith, G. P. Increased food intake after type A but not type B cholecystokinin receptor blockade. Physiol. Behav. 50:255-258; 1991.
3. 3. Crawley, J. N.; Fiske, S. M.; Durieux, C.; Derrien, M.; Roques, B. P. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism. J. Pharmacol. Exp. Ther. 257:1076-1080; 1991.
4. 4. Crawley, J. N.; Hommer, D. W.; Skirboll, L. R. Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat. Brain Res. 335:337-341: 1985.
5. 5. Crawley, J. N.; Stivers, J. A.; Blumstein, L. K.; Paul, S. M. Cholecystokinin potentiates dopamine-mediated behaviors: Evidence for modulation specific to a site of coexistence. J. Neurosci. 5 (8): 1972-1983; 1985.
6. 6. Della-Fera, M, A.; Baile, C. A. Cholecystokinin octapeptide: Continuous picomole injections into the cerebral ventricles of sheep suppress feeding. Science 206:471-473; 1979.
7. 7. Della-Fera, M. A.; Baue, C. A.; Schneider, B. S.; Grinker, J. A. Cholecystokinin antibody injected in cerebral ventricles stimulates feeding in sheep. Science 212:687-689; 1981.
8. A receptors. Eur. J. Pharmacol. 173:233-234; 1989.
9. B) receptors. Science 245:1509-1511; 1989.
10. A receptor antagonist, devazepide, blocks the anorectic action of CCK but not peripheral serotonin in rats. Pharmacol. Biochem. Behav. 43(3):943-947; 1992.
11. 11. Evans, K. R.; Vaccarino, F. J. Amphetamine- and morphine-induced feeding: Evidence for involvement of reward mechanisms. Neurosci. Biobehav. Rev. 14:9-22; 1990.
12. 12. Fallon, J. H.; Seroogy, K. B. The distribution and some connections of cholecystokinin neurons in the rat brain. Ann. NY Acad. Sci. 448:121-132; 1989.
13. 13. Garlicki, J.; Konturek, P. K.; Majka, J.; Kwiecien, N.; Konturek, S. J. Cholecystokinin receptors and vagal nerves in control of food intake in rats. Am. J. Physiol. 258:E40-E45; 1990.
14. 14. Gibbs, J.; Falasco, J. D.; McHugh, P. R. Cholecystokinin-decreased food intake in rhesus monkeys. Am. J. Physiol. 230(1):15-18; 1976.
15. 15. Gibbs, J.; Young, R. C.; Smith, G. P. Cholecystokinin elicits satiety in rats with open gastric fistulas. Nature 245:323-325; 1973.
16. 16. Heffner, T. G.; Zigmond, M. J.; Stricker, E. M. Effects of dopaminergic agonists and antagonists on feeding in intact and 6-hydroxydopamine-treated rats. J. Pharmacol. Exp. Ther. 201:386-399; 1977.
17. 17. Hernandez, L.; Hoebel, B. G. Feeding and hypothalamic stimulation increase dopamine turnover in the accumbens. Physiol. Behav. 44:599-608; 1988.
18. 18. Hernandez, L.; Hoebel, B. G. Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis. Life Sci. 42:1705-1712; 1988.
19. 19. Hewson, G.; Leighton, G. E.; Hill, R. G.; Hughes, J. The cholecystokinin receptor antagonist L364,718 increases food intake in the rat by attenuation of the action of endogenous cholecystokinin. Br. J. Pharmacol. 93:79-84; 1988.
20. 20. Higgins, G. A.; Sills, T. L.; Tomkins, D. M.; Sellers, E. M.; Vaccarino, F. J. Evidence for the contribution of CCKBCCKB receptor mechanisms to individual differences in amphetamine-induced locomotion. Pharmacol. Biochem. Behav. 48:1019-1024; 1994.
21. 21. Hokfelt, T.; Skirboll, L.; Rehfeld, J. F.; Goldstein, M.; Markey, K.; Dann, O. A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contain a cholecystokinin-like peptide: Evidence from immunohistochemistry combined with tracing. Neuroscience 5:2093-2124; 1980.
22. 22. Houpt, T. R.; Anika, S. M.; Wolff, N. C. Satiety effects of cholecystokinin and caerulein in rabbits. Am. J. Physiol. 235(1):R23-R28; 1978.
23. 23. Innis, R. B.; Snyder, S. H. Distinct cholecystokinin receptors in brain and pancreas. Proc. Natl. Acad. Sci. USA 77:6917-6921; 1980.
24. 24. Kelly, P. H.; Iversen, S. D. Selective 6OHDA induced destruction of mesolimbic dopamine neurons: Abolition of psychostimulant induced locomotor activity in rats. Eur. J. Pharmacol. 40:45-56; 1976.
25. 25. Khosla, S.; Crawley, J. N. Potency of L-364,718 as an antagonist of the behavioral effects of peripherally administered cholecystokinin. Life Sci. 42:153-159; 1988.
26. 26. Kissileff, H. R.; Pi-Sunyer, F. X.; Thornton, J.; Smith, G. P. C-terminal octapeptide of cholecystokinin decreases food intake in man. Am. J. Clin. Nutr. 34:154-160; 1981.
27. 27. Lewis, L. D.; Williams, J. A. Regulation of cholecystokinin secretion by food, hormones, and neural pathways in the rat. Am. J. Physiol. 258:G512-8; 1990.
28. 28. Marshall, F. H.; Barnes, S.; Hughes, J.; Woodruff, G. N.; Hunter, J. C. Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms. J. Neurochem. 56:917-922; 1991.
29. 29. McCaleb, M. L.; Myers, R. D. Cholecystokinin acts on the hypothalamic 'noradrenergic system' involved in feeding. Peptides 1:47-49; 1980.
30. A CCKA-receptor antagonist increases food intake in rats. Am. J. Physiol. 262:R216-R219; 1992.
31. 31. Moran, T. H.; Ameglio, P. J.; Schwarte, G. J.; McHugh, P. R. Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK. Am. J. Physiol. 262:R46-R50; 1992.
32. 32. Nemeroff, C. B.; Osbahr, A. J., III; Bissette, G. J.; Lipton, M. A.: Prange, A. J. Cholecystokinin inhibits tail pinch-induced eating in rats. Science 200:793-794; 1978.
33. 33. Paxinos, G.; Watson, C. The rat brain in stereotaxic atlas. New York: Academic Press; 1982.
34. 34. Reidelberger, R. D.; O'Rourke, M. F. Potent cholecystokinin antagonist L 364718 stimulates food intake in rats. Am. J. Physiol. 257:R1512-R1518; 1989.
35. 35. Reidelberger, R. D.; Varga, G.; Solomon, T. E. Effects of selective cholecystokinin antagonists L364,718 and L365.260 on food intake in rats. Peptides 12(6):1215-1221; 1991.
36. 36. Savory, C. J.; Gentle. M. J. Intravenous injections of cholecystokinin and caerulein suppress food intake in domestic fowls. Experientia 36:1191-1192; 1980.
37. 37. Schick, R. R.; Harty, G. J.; Yaksh, T. L.; Go, V. L. W. Sites in the brain at which cholecystokinin octapeptide (CCK-8) acts to suppress feeding in rats: A mapping study. Neuropharmacology 29(2): 109-118; 1990.
38. 38. Schneider, L. H.; Murphy, R. B.; Gibbs. J.; Smith, G. P. Comparative potencies of CCK antagonists for the reversal of the satiating effect of cholecystokinin. In: Wang, R. Y.; Schoenfeld, R., eds. Cholecystokinin antagonists. New York: Alan R. Liss, Inc.; 1988;263-284.
39. 39. Sharp, T.; Zetterstrom, T.; Ljungberg, T.; Ungerstedt, U. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res. 401:322-330; 1987.
40. 40. Sills, T. L.; Baird, J. P.; Vaccarino, F. J. Individual differences in the feeding effects of amphetamine: Role of nucleus accumbens dopamine and circadian factors. Psychopharmacology (Berlin) 112:233-241; 1993.
41. 41. Sills, T. L.; Vaccarino, F. J. Facilitation and inhibition of feeding by a single dose of amphetamine: relationship to baseline intake and accumbens cholecystokinin. Psychopharmacology (Berlin) 105:329-334; 1991.
42. 42. Silver, A. J.; Flood, J. F.; Song, A. M.; Morley, J. E. Evidence for a physiological role for CCK in the regulation of food intake in mice. Am. J. Physiol. 256:R646-R652; 1989.
43. 43. Smith, G.; Jerome, C.; Cushin, B. J.; Eterno, R.; Simansky, K. J. Abdominal vagatomy blocks the satiety effect of cholecystokinin in the rat. Science 213:1036-1037; 1981.
44. 44. Vaccarino, F. J. Nucleus accumbens dopamine-CCK interactions in psychostimulant reward and related behaviors. Neurosci. Biobehav. Rev. 18(2):207-214; 1994.
45. 45. Vaccarino, F. J.; Rankin, J. Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: Evidence for rostral-caudal differences in accumbens CCK function. Behav. Neurosci. 103:831-836; 1989.
46. 46. Vaccarino, F. J.; Schiff, B. B.; Glickman, S. E. Biological view of reinforcement. In: Klein. S. B.; Mowrer, R. R., eds. Contemporary learning theories. Hillsdale, NJ: Lawrence Erlabaum Assoc.; 1989:111-142.
47. 47. Vaccarino, F. J.; Vaccarino, A. L. Antagonism of cholecystokinin function in the rostral and caudal nucleus accumbens: Differential effects on brain stimulation reward. Neurosci. Lett. 97:151-156; 1989.
48. 48. Willis, G. L.; Hansky, J.; Smith, G. C. Central and peripheral proglumide administration and cholecystokinin-induced satiety. Regul. Pept. 15:87-98; 1986.
49. 49. Wise, R. A.; Bozarth, M. A. Brain reward circuitry: four circuit elements "wired" in apparent series. Brain Res. Bull. 12(2):203-208; 1987.